Single-Agent Versus Combination Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2: Prognostic Factors and Treatment Selection Based on Two Large Randomized Clinical Trials
Keywords: NSCLC; Performance status 2; Paclitaxel poliglumex; Gemcitabine; Vinorelbine; STELLAR; Prognostic model; Combination chemotherapy; Single-agent chemotherapy